Concepedia

Alwine B. Kruisselbrink

AB

22

Publications

2.6K

Citations

17

H-Index

2001

Active since

Affiliations

Leiden University Medical Center(Current)

Leiden University

Centre for Human Drug Research

The Netherlands Cancer Institute

Oncode Institute

Alwine B. Kruisselbrink is an author at Leiden University Medical Center specializing in medicine, cell biology, and regenerative medicine.

ORCID

Top concepts

Publications per year

2001–2022

22

Publications

22

Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells

Alma J. Nauta, Alwine B. Kruisselbrink, Ellie G.A. Lurvink et al. · The Journal of Immunology · 2006 · 714 citations

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

Alma J. Nauta, Geert Westerhuis, Alwine B. Kruisselbrink et al. · Blood · 2006 · 696 citations · Full text

Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice

Willy A. Noort, Alwine B. Kruisselbrink, Pieternella S. in't Anker et al. · Experimental Hematology · 2002 · 490 citations

, , +12

Nonexpanded primary lung and bone marrow–derived mesenchymal cells promote the engraftment of umbilical cord blood–derived CD34+ cells in NOD/SCID mice

Pieternella S. in `t Anker, Willy A. Noort, Alwine B. Kruisselbrink et al. · Experimental Hematology · 2003 · 147 citations

, , +13

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Sanja Stevanović, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs et al. · Blood · 2013 · 79 citations · Full text

Rows per page

1–5 of 22